Cost-effectiveness analysis of additional local prostate radio therapy in metastatic prostate cancer from a medicare perspective
Abstract Background Metastatic prostate cancer remains a therapeutic challenge. Based on data of the STAMPEDE trial, patients with a low metastatic burden showed prolonged failure-free and overall survival when treated with prostate radio therapy (RT) in addition to standard of care (SOC). The objec...
Saved in:
| Main Authors: | Kristina K. M. Kramer, Nina-Sophie Schmidt-Hegemann, Thilo Westhofen, Marco Foglar, Jens Ricke, C. Benedikt Westphalen, Marcus Unterrainer, Wolfgang G. Kunz, Dirk Mehrens |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Radiation Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13014-024-02544-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metastatic brain lesions in prostate cancer
by: P. G. Berezin, et al.
Published: (2025-06-01) -
A case of multiple bone metastases during the course of non‐invasive bladder and prostate cancer
by: Keisuke Matsubara, et al.
Published: (2025-03-01) -
Metastase Tulang pada Kanker Lambung
by: Dukut Respati Kastomo
Published: (2007-08-01) -
Prostatic duct adenocarcinoma—A challenging variant of prostate cancer in a low‐resource setting
by: Ronald Okidi, et al.
Published: (2024-11-01) -
Uterine leiomyomas and metastases: description of a case
by: T. I. Zakharova, et al.
Published: (2014-08-01)